A Long-term Follow-up Study of Patients Who Received VOR33
Leukemia, Myeloid, AcuteVOR33 long-term follow-up (LTFU) study
null
Conditions de participation
-
Sexe:
ALL -
Âges admissibles:
0 and up
Critères de participation
Inclusion Criteria:
* A patient is included in this study if he/she:
1. Has received any part of or all of a VOR33 infusion
Exclusion Criteria:
* There are no exclusion criteria.
Lieu de l'étude
Hôpital Maisonneuve-Rosemont
Hôpital Maisonneuve-RosemontMontréal, Quebec
Canada
Contactez l'équipe d'étude
- Étude parrainée par
- Vor Biopharma
- Participants recherchés
- Plus d'informations
- ID de l'étude:
NCT05309733